Divestitures

September 29, 2008

Target: Neose Technologies Inc - Certain Assets (2836)

Certain asts

United States

RBC Capital MarketsAcquiror: Investor Group (6799)

Investor group

Denmark

Deal InformationValue:

Type:

Announced:43.0

Acq. Cert. Asts.

09/18/08US - An investor group, comprised of Novo Nordisk A/S and BioGenerix AG, definitively agreed to acquire certain assets of Neose Technologies Inc (NT), a biopharmaceutical company, for an estimated $43 mil in cash. The transaction was subject to customary closing conditions and NT shareholders approval.…

The full article is available to Mergers Unleashed subscribers only

Are you an existing M&A Magazine subscriber and/or ACG member?

 Yes     No

Already a print subscriber? As a print subscriber, you are entitled to online access. Please click here to activate your account.